ClinicalTrials.gg
CompletedNCT02094456Updated Aug 13, 2020

Prophylactic Elective Clipping of Colonic Diverticula

An interventional study of Endoscopic clipping of diverticula and Follow-up colonoscopy in Diverticular Disease, sponsored by King's College Hospital NHS Trust. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-08-13.

Sponsored by King's College Hospital NHS Trust · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
9
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Diverticular bleeding is the most common cause of acute lower gastrointestinal bleeding (LGIB) in Western populations. Although self-limited in 85% of cases, some patients may require hospitalization with blood transfusion and emergent intervention, with significant associated morbidity and mortality. Up to 25% of patients with an initial bleeding episode will have subsequent episodes.

Diverticula form at weak points along the colon wall, where the vasa recta enter the circular muscle layer of the colon. Diverticular bleeding is attributed to thinning of the blood vessels as they cross over the dome of a diverticulum. Endoscopic clipping of actively bleeding colonic diverticula has been recognized as a safe and effective treatment for acute LGIB since the mid1990s. Patients selected would have had previous colonoscopy to exclude other causes of bleeding (e.g. angiodysplasia, colorectal cancer).

The investigators propose prophylactic elective endoscopic diverticular clipping in patients who have had at least 1 episode of acute LGIB requiring hospitalization. This would involve applying endoscopic clips to the base of every diverticula in a patient's colon, such that any bleeding source would effectively be excluded. The investigators would later reevaluate patients for colonoscopic appearance of diverticula to assess their diverticular disease.

The investigators hypothesize that patients undergoing endoscopic diverticular clipping will not have repeat episodes of bleeding.

Read the detailed description

1.0 BACKGROUND AND HYPOTHESES

The investigators aim to prophylactically clip all colonic diverticula in patients who have experienced at least 1 episode of diverticular bleeding requiring hospitalization, but without definitive procedure (i.e., total colectomy or localization with embolization or clipping). The investigators' objective is to prevent future episodes of colonic bleeding from the diverticula, so as to avoid morbidity and possible mortality.

The investigators hypothesize that those patients undergoing secondary prophylaxis through diverticular clipping will experience no further episodes of diverticular bleeding.

2.0 OBJECTIVES AND PURPOSE

Diverticular bleeding is the most common cause of acute lower gastrointestinal bleeding (LGIB) in Western populations. Although self-limited in 85% of cases, some patients may require hospitalization with blood transfusion and emergent intervention, with significant associated morbidity and mortality. Up to 25% of patients with an initial bleeding episode will have subsequent episodes.

Diverticula form at weak points along the colon wall, where the vasa recta enter the circular muscle layer of the colon. Diverticular bleeding is attributed to thinning of the blood vessels as they cross over the dome of a diverticulum. Endoscopic clipping of actively bleeding colonic diverticula has been recognized as a safe and effective treatment for acute LGIB since the mid-1990s. Patients selected would have had previous colonoscopy to exclude other causes of bleeding (e.g. angiodysplasia, colorectal cancer).

The investigators propose prophylactic elective endoscopic diverticular clipping in patients who have had at least 1 episode of acute LGIB requiring hospitalization. This would involve applying endoscopic clips to the base of every diverticula in a patient's colon, such that any bleeding source would effectively be excluded. The investigators would later re-evaluate patients for colonoscopic appearance of diverticula, as there is some suggestion that diverticula may resolve after such management.

3.0 STUDY DESIGN

The investigators propose a prospective feasibility study of outpatients who have previously been hospitalized with at least one episode of diverticular bleeding. Diverticular disease will have been confirmed by previous colonoscopy to assess the extent of diverticular disease. Consecutive patients at follow-up outpatient appointments will be approached with a Patient Information Sheet. On follow-up appointment they will be recruited and enrolled for endoscopic clipping of colonic diverticula.

The procedure itself will be similar to a screening colonoscopy. As outpatients, patients will take bowel preparation. Colonoscopy will occur with sedation only, including fentanyl and midazolam per protocol. Individual colonic diverticula will be clipped to exclude the bleeding source.

Twenty-four (24) patients will be enrolled for diverticular clipping. These patients will be followed prospectively for 2 years for repeat bleeding episodes. Follow-up will consist of telephone calls every 6 months by the study team. In addition, patients will be scheduled for repeat colonoscopy to assess their diverticular disease 6 months after clipping of colonic diverticula.

4.0 SELECTION AND WITHDRAWAL OF SUBJECTS Currently, patients admitted with complications of diverticular disease are seen in Diverticular Disease clinic for follow-up. Consecutive patients will be selected from this patient population.

Patients may withdrawal from the study at any time, including during the colonoscopy with clipping of diverticula.

5.0 DATA COLLECTION AND MONITORING

Data collection will take place on a specially created case report form (See case report form version 1.2). Case report forms will be stored in a locked office in the Department of Colorectal Surgery accessible only to the study team. Data will be entered into an excel spreadsheet. The spreadsheet will be kept on a password protected NHS desktop in a locked office in the Department of Colorectal Surgery.

6.0 STATISTICAL CONSIDERATIONS

As this is a feasibility study, recruited patients will be study prospectively. Any analysis will include all patients enrolled. There will be no control group or randomization at this time.

02

Conditions studied

  • Diverticular Disease

Browse trials for

Keywords

  • diverticular disease
  • diverticular bleeding
  • endoscopic clipping
  • endoscopy
  • lower gastrointestinal bleeding
03

In context

Diverticular Diseases

44 studies on the registry are indexed under Diverticular Diseases; 9 are open to participants now.

This study's enrollment of 9 is below the median of 81 across 31 interventional studies indexed under Diverticular Diseases.

Browse Diverticular Diseases studies →

Lead sponsor

King's College Hospital NHS Trust is the lead sponsor of 171 studies on the registry; 56 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients will be included if they have been hospitalized at least once with diverticular bleeding.

Exclusion criteria

Exclusion Criteria:

  • Patients who had a definitive procedure to stop diverticular bleeding, including colectomy or angiography with embolization.
  • Patients who are considered too high risk for colonoscopy or bowel preparation. There will be no exclusion criteria based on age. Rather, patients will be individually evaluated and judged for frailty.
  • Patients on anticoagulant agents that may not be stopped for colonoscopy.
  • Patients without colonic diverticula
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
9 participants (actual)

Study arms

  • Experimental
    Endoscopic clipping of diverticula

    Endoscopic clipping of diverticula Follow-up colonoscopy

    Procedure: Endoscopic clipping of diverticula · Procedure: Follow-up colonoscopy

Interventions

  • ProcedureEndoscopic clipping of diverticula

    Colonoscopy with identification of each individual colonic diverticula and endoscopic clipping.

  • ProcedureFollow-up colonoscopy

    Patients will undergo a repeat colonoscopy 6 months after endoscopic clipping procedure.

06

What researchers measure

Primary outcomes

  1. The primary outcome will be episodes of recurrent bleeding requiring hospitalization.

    Postprocedure, patients will follow-up every 6 months either in Diverticular Disease clinic or via telephone checkup. These visits will ascertain whether patients have had recurrent bleeding episodes.

    Time frame: 12 months

07

Study locations

1 site
  • King's College Hospital
    London, SE5 9RS, United Kingdom
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2016 to primary completion in Apr 2017, 12 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 20, 2014
First posted
Mar 21, 2014
StartActual
Apr 1, 2016
Primary completionActual
Apr 1, 2017
CompletionActual
May 5, 2018
Last update
Aug 13, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 13, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02094456
Responsible party
Sponsor
First posted
Mar 21, 2014
Start date
Apr 1, 2016
Primary completion
Apr 1, 2017
Completion
May 5, 2018
Last update
Aug 13, 2020

Study contacts

Amyn Haji, MSc MD FRCS
principal investigator · King's College Hospital NHS Trust
Charlotte Kvasnovsky, MD MPH
study director · King's College Hospital NHS Trust

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion